Brain serotonin transporter binding in former users of MDMA ('ecstasy').

Brain serotonin transporter binding in former users of MDMA ('ecstasy').

BACKGROUND: Animal experimental studies have prompted concerns that widespread use of 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy') by young people may pose a major public health problem in terms of persistent serotonin neurotoxicity. AIMS: To determine the status of brain serotonin...

Full description

Bibliographic Details
Main Authors:	Selvaraj, S, Hoshi, R, Bhagwagar, Z, Murthy, N, Hinz, R, Cowen, P, Curran, H, Grasby, P
Format:	Journal article
Language:	English
Published:	2009

Similar Items

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users.
by: Semple, D, et al.
Published: (1999)

Effects of citalopram infusion on the serotonin transporter binding of [11C]DASB in healthy controls.
by: Hinz, R, et al.
Published: (2008)

The effects of ecstasy (MDMA) on brain serotonin transporters are dependent on age-of-first exposure in recreational users and animals.
by: Anne Klomp, et al.
Published: (2012-01-01)

Serotonin transporters in ecstasy users - Reply
by: Ebmeier, K, et al.
Published: (2000)

Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASB.
by: Selvaraj, S, et al.
Published: (2011)

Induced fit, ensemble binding space docking and Monte Carlo simulations of MDMA ‘ecstasy’ and 3D pharmacophore design of MDMA derivatives on the human serotonin transporter (hSERT)
by: Ángel A. Islas, et al.
Published: (2021-08-01)

Ecstasy (MDMA): effects and patterns of use reported by users in São Paulo
by: Almeida Stella Pereira de, et al.
Published: (2003-01-01)

Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): Neurodegeneration versus Neuromodulation
by: Elena Puerta, et al.
Published: (2011-07-01)

Aromatic Bromination Abolishes the Psychomotor Features and Pro-social Responses of MDMA (“Ecstasy”) in Rats and Preserves Affinity for the Serotonin Transporter (SERT)
by: Patricio Sáez-Briones, et al.
Published: (2019-02-01)

5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.
by: Bhagwagar, Z, et al.
Published: (2007)

Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain.
by: Murthy, N, et al.
Published: (2010)

3,4-methylenedioxymethamphetamine (MDMA, or "ecstasy") and associated hypoglycemia.
by: Montgomery, H, et al.
Published: (1997)

Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635.
by: Bhagwagar, Z, et al.
Published: (2004)

Caffeine and MDMA (Ecstasy) Exacerbate ER Stress Triggered by Hyperthermia
by: Kathleen A. Trychta, et al.
Published: (2022-02-01)

Ecstasy (MDMA) and its effects on kidneys and their treatment: a review
by: Feyza Bora, et al.
Published: (2016-11-01)

Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naive controls.
by: Morgan, M, et al.
Published: (2006)

Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database
by: Tigran Makunts, et al.
Published: (2022-01-01)

The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls.
by: Roiser, J, et al.
Published: (2006)

A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)
by: João Paulo Capela, et al.
Published: (2022-01-01)

Ecstasy (MDMA) and its Relationship with Self-Report Depression, Anxiety and Schizotypy
by: Lisa Wood, et al.
Published: (2010-01-01)

Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.
by: Bhagwagar, Z, et al.
Published: (2006)

Lack of effect of a single dose of hydrocortisone on serotonin(1A) receptors in recovered depressed patients measured by positron emission tomography with [11C]WAY-100635.
by: Bhagwagar, Z, et al.
Published: (2003)

Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.
by: Hinz, R, et al.
Published: (2007)

Acute ascending aortic dissection after MDMA/ecstasy use: A case report
by: Satoko Kanahara, MD, et al.
Published: (2016-09-01)

Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice
by: V. Ferraz-de-Paula, et al.
Published: (2011-05-01)

Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data
by: Stefania Salvatore, et al.
Published: (2016-07-01)

State and trait abnormalities in serotonin function in major depression.
by: Bhagwagar, Z, et al.
Published: (2002)

Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.
by: Meyer, P, et al.
Published: (2010)

Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells.
by: Dina Popova, et al.
Published: (2016-01-01)

Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents
by: Grant Jones, et al.
Published: (2022-12-01)

Erratum to: Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data
by: Stefania Salvatore, et al.
Published: (2017-02-01)

Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study.
by: Cédric M Hysek, et al.
Published: (2012-01-01)

Chronic exposure to MDMA (Ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants
by: Swann Alan C, et al.
Published: (2006-01-01)

Nephroprotective effects of Feijoa Sellowiana leaves extract on renal injury induced by acute dose of ecstasy (MDMA) in mice
by: Mohammad Karami, et al.
Published: (2014-01-01)

HPLC Measurement of MDMA Content in Ecstasy Tablets Available in the Black Market of West Azerbaijan Province, Northwestern Iran
by: Reza Ghafari, et al.
Published: (2014-12-01)

Anestesia e o usuário de Ecstasy Anestesia y el usuario de Ecstasy Anesthesia and the Ecstasy user
by: Eduardo Toshiyuki Moro, et al.
Published: (2006-04-01)

Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample
by: Grant Jones, et al.
Published: (2023-02-01)

Pentoxifylline Protects the Rat Liver Against Fibrosis and Apoptosis Induced by Acute Administration of 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy)
by: Shabnam Movassaghi, et al.
Published: (2013-08-01)

A Study on Psychodinamic of the User of Ecstasy
by: Luís Sérgio Sardinha, et al.
Published: (2000-07-01)

Allosteric Binding of MDMA to the Human Serotonin Transporter (hSERT) via Ensemble Binding Space Analysis with ΔG Calculations, Induced Fit Docking and Monte Carlo Simulations
by: Ángel A. Islas, et al.
Published: (2022-05-01)